Overview of targeted therapies in Oncology
Author:
- 1 December 2007
- journal article
- Published by SAGE Publications in Journal of Oncology Pharmacy Practice
- Vol. 13 (4) , 199-205
Abstract
Background: Recent scientific advances have provided a map of the human genome along with a better understanding of the processes that transform healthy cells into diseased cells. This has led to the emergence of a new class of drugs called targeted therapies. Objective: To describe the classifications and basic pharmacology of targeted therapies. Methods: A literature search was performed for peer reviewed journal articles using Medline (1996—2007), Embase (1996—2007) and Google. The search was performed using keywords such as angiogenesis inhibitors, cancer vaccines, gene therapy, monoclonal antibodies, small molecules, proteasome inhibitors, targeted therapy and tyrosine kinase inhibitors. Conclusions: A review of the basic pharmacology is described in this article, including the following major categories of targeted therapies: • Small molecule drugs • Monoclonal antibodies • Apoptosis-inducing drugs • Angiogenesis Inhibitors • Cancer vaccines • Gene therapy J Oncol Pharm Practice (2007) 13: 199—205.Keywords
This publication has 8 references indexed in Scilit:
- Gene Therapy for Cancer Treatment: Past, Present and FutureClinical Medicine & Research, 2006
- Defining and Managing Imatinib ResistanceHematology-American Society Hematology Education Program, 2006
- Defining and Managing Imatinib ResistanceHematology-American Society Hematology Education Program, 2006
- Keys to Unlock Cancer: Targeted TherapyOncology Nursing Forum, 2005
- Targeted Therapies for Cancer 2004American Journal of Clinical Pathology, 2004
- The promise of targeted therapy: cancer drugs become more specific.Cleveland Clinic Journal of Medicine, 2004
- The cancer growth suppressor gene mda- 7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude miceProceedings of the National Academy of Sciences, 1998
- Cellular and Molecular Neurosurgery: Pathways from Concept to Reality-Part I: Target Disorders and Concept Approaches to Gene Therapy of the Central Nervous SystemNeurosurgery, 1997